Alkyl Amines Chemicals Limited posted a robust growth in its net profit during first quarter of the current fiscal year.

 

The consolidated net profit in Q1FY21 came in at Rs 52.78 crore which rose  by 50.41%, as compared to Q1FY20, when it reported Rs 35.09 crore. The net profit margin in Q1FY21 came in at 21.53% which rose by 8.35% yoy. The net profit margin for Q1FY20 was at 13.18%

 

Revenue in Q1FY21 stood at Rs 245.15 crore, which declined by 7.92% yoy from Rs 266.23 crore in Q1FY20.

 

EBITDA stood at Rs 77.38 crore in Q1FY21 that rose by 30.8% yoy. For Q1FY20, it had posted EBITDA of Rs 59.16 crore. EBITDA margin as of Q1FY21 was at 31.56% that rose  by 9.34% yoy against the same quarter, the previous year.

 

The company is in the business of manufacture and sale of essential products, being mainly pharmaceutical intermediates and is well positioned to fulfill its existing orders and contracts. The company has been able to meet all its operational needs and is in a comfortable liquidity position to meet its financial commitments. There is no impact on capital and financial resources of the company.

 

The assets have not been impacted as a result of the pandemic. The company contirues to abide by the directives and advisories issued by various Government authorities and evaluate the impact of Covid--19 as the situation evolves. While there has not been materially adverse impact of Covid-19 on the company's business operations so far, it is extremely difficult to assess future impact. The company expects that the demand for its products from pharmaceutical sector will continue and, as such, barring unforeseen circumstances there will not be a significant impact of Covid-19 on the

operations of the company.